SuperworthKewaunee Scientific profit margin KEQU
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 3.0%
- Operating margin, 12 months
- 5.4%
- Net margin on a year earlier
- −1.7 pts
- Peer median
- 7.1%
Over the twelve months to Jul 31, 2026, Kewaunee Scientific kept 3.0% of its revenue as net profit, with an operating margin of 5.4% and a gross margin of 28.6%.
Five years earlier its net margin was −2.9%.
The median for 9 medical instruments and supplies stocks of a similar size is 7.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 3.4% | 5.9% | 28.5% |
| FY2025 | 4.7% | 7.4% | 28.6% |
| FY2024 | 9.2% | 9.0% | 25.5% |
| FY2023 | 0.3% | 2.4% | 16.2% |
| FY2022 | −3.6% | −1.5% | 14.3% |
| FY2021 | −2.5% | −0.9% | 16.3% |
| FY2020 | −3.2% | −1.6% | 15.9% |
| FY2019 | 1.0% | 1.3% | 17.3% |
| FY2018 | 3.3% | 6.3% | 20.3% |
| FY2017 | 3.3% | 4.7% | 19.2% |
| FY2016 | 3.0% | 4.4% | 18.4% |
| FY2015 | 3.0% | 4.4% | 18.3% |
| FY2014 | 3.5% | 5.4% | 19.8% |
| FY2013 | 2.6% | 4.5% | 19.0% |
| FY2012 | 1.0% | 2.6% | 18.6% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q1 FY27 | 3.0% | −1.7 pts | 5.4% | |
| Q4 FY26 | 3.4% | −1.3 pts | 5.9% | |
| Q3 FY26 | 3.9% | −4.1 pts | 7.0% | |
| Q2 FY26 | 4.1% | −5.3 pts | 6.9% | |
| Q1 FY26 | 4.7% | −4.5 pts | 7.6% | |
| Q4 FY25 | 4.7% | −4.5 pts | 7.4% | |
| Q3 FY25 | 8.0% | +3.6 pts | 6.7% | |
| Q2 FY25 | 9.4% | +6.2 pts | 8.2% | |
| Q1 FY25 | 9.1% | +7.3 pts | 8.4% | |
| Q4 FY24 | 9.2% | +8.9 pts | 9.0% | |
| Q3 FY24 | 4.3% | +4.6 pts | 7.7% | |
| Q2 FY24 | 3.2% | +4.6 pts | 6.5% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Kewaunee Scientific's size, closest first, today.
| Company | Profit margin |
|---|---|
| KEQUKewaunee Scientific | 3.0% |
| APTAlpha Pro Tech | 6.8% |
| PDEXPro DEX | 17.6% |
| NEPHNephros | 8.4% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| Peer median | 7.1% |
Where Kewaunee Scientific ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Kewaunee Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.